Long Beach, CALIFORNIA2 Active Studies

Huntingtons Disease Clinical Trials in Long Beach, CALIFORNIA

Find 2 actively recruiting huntingtons disease clinical trials in Long Beach, CALIFORNIA. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
594
Enrolling

Recruiting Huntingtons Disease Studies in Long Beach

About Huntingtons Disease Clinical Trials in Long Beach

Huntington's disease is an inherited condition that causes progressive degeneration of nerve cells in the brain, affecting movement, cognition, and behavior. It is caused by a mutation in the HTT gene. Current treatments manage symptoms, while gene-silencing therapies are being studied.

There are currently 2 huntingtons disease clinical trials recruiting participants in Long Beach, CALIFORNIA. These studies are seeking a combined 594 participants. Research is being sponsored by Otsuka Pharmaceutical Development & Commercialization, Inc., Supernus Pharmaceuticals, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.

Huntingtons Disease Clinical Trials in Long Beach — FAQ

Are there huntingtons disease clinical trials in Long Beach?

Yes, there are 2 huntingtons disease clinical trials currently recruiting in Long Beach, CALIFORNIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Long Beach?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Long Beach research site will contact you about next steps.

Are clinical trials in Long Beach free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Long Beach studies also compensate for your time and travel.

What huntingtons disease treatments are being tested?

The 2 active trials in Long Beach are testing new therapies including novel drugs, biologics, and treatment approaches for huntingtons disease.

Data updated March 2, 2026 from ClinicalTrials.gov